Patents by Inventor Pawel Kamil DOMINIK

Pawel Kamil DOMINIK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies Specific for CD47, PD-L1, and Uses Thereof
    Publication number: 20240124591
    Abstract: Antibodies that specifically bind to CD47 and antibodies that specifically bind to PD-L1 are provided, as well as CD47/PD-L1 bispecific antibodies. Also provided are uses of these antibodies, and related compositions and methods.
    Type: Application
    Filed: May 18, 2023
    Publication date: April 18, 2024
    Applicant: Pfizer Inc.
    Inventors: Javier Fernando CHAPARRO RIGGERS, Shih-Hsun CHEN, Sheng DING, Pawel Kamil DOMINIK, Shahram SALEK-ARDAKANI, Jessica Lynn Stanfield, Thomas John VAN BLARCOM
  • ANTI-LYMPHOTOXIN BETA RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20230365701
    Abstract: Antibodies that specifically bind to LTBR are provided. Also provided are uses of these antibodies, and related compositions and methods.
    Type: Application
    Filed: May 10, 2023
    Publication date: November 16, 2023
    Applicant: Pfizer Inc.
    Inventors: James Reasoner APGAR, Bas Joannes Gertrudis BAATEN, Aruna BITRA, Javier Fernando CHAPARRO RIGGERS, Giuseppe DI CARO, Pawel Kamil DOMINIK, Zachary John MABEN, Lidia MOSYAK, Andrew Ross NAGER, Cecilia Marianne ODERUP, Edward Derrick PASCUA, Shahram SALEK-ARDAKANI, Dirk Michael ZAJONC
  • Antibodies specific for CD47, PD-L1, and uses thereof
    Patent number: 11702474
    Abstract: Antibodies that specifically bind to CD47 and antibodies that specifically bind to PD-L1 are provided, as well as CD47/PD-L1 bispecific antibodies. Also provided are uses of these antibodies, and related compositions and methods.
    Type: Grant
    Filed: December 14, 2020
    Date of Patent: July 18, 2023
    Assignee: Pfizer Inc.
    Inventors: Javier Fernando Chaparro Riggers, Shih-Hsun Chen, Sheng Ding, Pawel Kamil Dominik, Shahram Salek-Ardakani, Jessica Lynn Stanfield, Thomas John Van Blarcom
  • Antibodies Specific for CD47, PD-L1, and Uses Thereof
    Publication number: 20210179716
    Abstract: Antibodies that specifically bind to CD47 and antibodies that specifically bind to PD-L1 are provided, as well as CD47/PD-L1 bispecific antibodies. Also provided are uses of these antibodies, and related compositions and methods.
    Type: Application
    Filed: December 14, 2020
    Publication date: June 17, 2021
    Applicant: Pfizer Inc.
    Inventors: Javier Fernando CHAPARRO RIGGERS, Shih-Hsun CHEN, Sheng DING, Pawel Kamil DOMINIK, Shahram SALEK-ARDAKANI, Jessica Lynn Stanfield, Thomas John VAN BLARCOM